Annual Drug Patent Expirations for ONZETRA+XSAIL
Onzetra Xsail is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.
ONZETRA XSAIL drug price trends.
This drug has two hundred and fifty-four patent family members in twenty-nine countries.
The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. One supplier is listed for this compound. Additional details are available on the sumatriptan succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
